Medicare Enrolled
Dr. Emmalind Aponte, MD
Hematology & Oncology · San Antonio, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Aponte from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Aponte?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Aponte
Dr. Emmalind Aponte is a hematology & oncology specialist in San Antonio, TX, with 18 years of NPI registration. Based on federal Medicare data, Dr. Aponte performed 42,743 Medicare services across 2,322 unique beneficiaries.
Between the years covered by Open Payments, Dr. Aponte received a total of $9,434 from 50 pharmaceutical and/or device companies across 401 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Aponte is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 23% volume in TX
$9,434 industry payments
Medicare Practice Summary
Medicare Utilization ↗42,743
Medicare services
Top 23% in TX for hematology & oncology
2,322
Unique beneficiaries
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,375 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
12,310 | $2 | $20 |
| Azacitidine chemotherapy injection An injection of the medication azacitidine, measured at 1 mg per unit. |
9,550 | $0 | $13 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
6,600 | $0 | $5 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
4,768 | $0 | $3 |
| Denosumab injection (Prolia/Xgeva) | 1,260 | $18 | $66 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,064 | $0 | $1 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
768 | $8 | $20 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
694 | $8 | $36 |
| Injection, granisetron hydrochloride, 100 mcg | 690 | $0 | $24 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
612 | $10 | $64 |
| Anti-nausea injection (Aloxi/palonosetron) | 600 | $1 | $114 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
539 | $64 | $250 |
| Flow cytometry, additional marker An additional marker is tested during a flow cytometry procedure to analyze DNA or cells. This step adds specific data points to the initial analysis. |
514 | $17 | $180 |
| Pegfilgrastim injection, 0.5 mg An injection of pegfilgrastim, a medication that stimulates the production of white blood cells. This specific code applies to the brand-name drug and excludes biosimilar versions. |
252 | $82 | $1,348 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
221 | $22 | $157 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
179 | $89 | $368 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
178 | $95 | $707 |
| Immunoglobulin light chain measurement A blood test that measures the levels of immunoglobulin light chains, which are proteins produced by plasma cells. |
140 | $16 | $60 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
120 | $54 | $211 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
118 | $6 | $431 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
103 | $13 | $60 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
102 | $6 | $31 |
| Iron level test | 98 | $6 | $27 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
98 | $8 | $35 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
95 | $10 | $96 |
| Automated red blood cell count with calculations A blood test that automatically counts red blood cells and performs additional calculations to assess blood health. |
94 | $5 | $26 |
| Manual white blood cell count A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present. |
88 | $4 | $22 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
88 | $6 | $34 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
75 | $15 | $76 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
72 | $46 | $313 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
70 | $59 | $247 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
68 | $118 | $565 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
59 | $11 | $108 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
56 | $49 | $344 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
55 | $1 | $7 |
| Reticulated platelet measurement A blood test that measures the level of young, newly formed platelets in the body. |
50 | $35 | $143 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
42 | $45 | $821 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
42 | $91 | $357 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
40 | $165 | $1,067 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
27 | $14 | $100 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
22 | $18 | $114 |
| On-body injector for subcutaneous injection A device is applied to the skin to automatically deliver a medication injection under the skin. |
21 | $14 | $96 |
| Flow cytometry DNA or cell analysis, first marker A laboratory test that uses a laser to analyze cells or DNA by detecting a specific marker on the cell surface or within the cell. |
20 | $53 | $298 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
15 | $23 | $256 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
14 | $14 | $73 |
| Serum protein measurement A blood test that measures the total amount of protein in the serum. It helps evaluate overall health and nutritional status. |
14 | $11 | $99 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
14 | $100 | $470 |
| Serum immunofixation test A laboratory test that analyzes a blood serum sample to identify specific abnormal proteins. The procedure uses an immunologic technique to detect and characterize these proteins. |
13 | $22 | $160 |
| CT scan for bone mineral density A CT scan used to measure calcium and other minerals in the bone. This procedure assesses bone mineral content. |
11 | $92 | $447 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.3% high complexity
88.1% medium
10.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,434
Total received (2018-2024)
Avg $1,348/year across 7 years
Top 33% in TX for hematology & oncology
50
Companies
401
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,232 (97.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$202 (2.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$784
2023
$967
2022
$360
2021
$133
2020
$527
2019
$2,364
2018
$4,299
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$757
E.R. Squibb & Sons, L.L.C.
$732
AstraZeneca Pharmaceuticals LP
$675
Myriad Genetic Laboratories, Inc.
$658
Janssen Biotech, Inc.
$650
Amgen Inc.
$648
Takeda Pharmaceuticals U.S.A., Inc.
$634
PFIZER INC.
$347
Genentech USA, Inc.
$345
Incyte Corporation
$342
AbbVie, Inc.
$291
Merck Sharp & Dohme Corporation
$279
Janssen Pharmaceuticals, Inc
$264
Bayer HealthCare Pharmaceuticals Inc.
$183
Seattle Genetics, Inc.
$169
GENZYME CORPORATION
$155
Astellas Pharma US Inc
$150
Gilead Sciences, Inc.
$149
Exelixis Inc.
$141
Ipsen Biopharmaceuticals, Inc
$140
Agios Pharmaceuticals, Inc.
$139
EMD Serono, Inc.
$134
Pharmacyclics LLC, An AbbVie Company
$129
Genmab U.S., Inc.
$125
Bayer Healthcare Pharmaceuticals Inc.
$125
G1 Therapeutics, Inc.
$125
TESARO, Inc.
$102
Merck Sharp & Dohme LLC
$101
Lilly USA, LLC
$98
Verastem, Inc.
$89
Alexion Pharmaceuticals, Inc.
$63
Eisai Inc.
$57
Celgene Corporation
$53
Boehringer Ingelheim Pharmaceuticals, Inc.
$43
Jazz Pharmaceuticals Inc.
$42
Apellis Pharmaceuticals, Inc.
$30
Daiichi Sankyo Inc.
$29
Otsuka America Pharmaceutical, Inc.
$29
Clovis Oncology, Inc.
$26
SANOFI PASTEUR INC.
$24
JAZZ PHARMACEUTICALS INC.
$22
ARRAY BIOPHARMA INC
$21
Regeneron Healthcare Solutions, Inc.
$17
INSYS Therapeutics Inc
$17
Helsinn Therapeutics (U.S.), Inc.
$16
Medtronic USA, Inc.
$15
Novo Nordisk Inc
$15
Spectrum Pharmaceuticals Inc.
$13
AMAG Pharmaceuticals, Inc.
$12
Sandoz Inc.
$11
Top 3 companies account for 22.9% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALOXI · Aliqopa · Avastin · BRACAnalysis · Balversa · Bavencio · Blincyto · CABLIVI · CALQUENCE · COSELA · CYRAMZA · Cabometyx · Copiktra · DARZALEX · ELITEK · EMEND · EMPLICITI · EXKIVITY · Empaveli · Epkinly · Erleada · FERAHEME · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FRUZAQLA · Folotyn · GILOTRIF · Halaven · IBRANCE · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · Imbruvica · JADENU · JAKAFI · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LYNPARZA · Lenvima · MEKINIST · MYCHOICE CDX · MYLOTARG · MYRISK · NINLARO · Neulasta · Nexavar · Nplate · Nubeqa · OPDIVO · OPDUALAG · OSTEOCOOL RF ABLATION · Onivyde · Ozempic · PIQRAY · PRECISETUMOR · PROMACTA · Perjeta · RETEVMO · RYDAPT · Revlimid · Rubraca · SARCLISA · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYNDROS · TAGRISSO · TALZENNA · TASIGNA · TECENTRIQ · TIBSOVO · Trodelvy · ULTOMIRIS · VENCLEXTA · VOTRIENT · VYXEOS · Vectibix · Venclexta · XALKORI · XARELTO · XGEVA · XOSPATA · XTANDI · Xofigo · ZARXIO · ZEJULA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $22 per 100 Medicare services performed
Geographic Context
Hematology & oncology specialists within 10 mi
56
Per 100K population
2.7
County median income
$70,571
Nearest hospital
SAN ANTONIO BEHAVIORAL HEALTHCARE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Aponte is a mixed practice specialist, with above-average Medicare volume (top 23% in TX), with low-engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Aponte experienced with darbepoetin injection (aranesp) for anemia?
Based on Medicare claims data, Dr. Aponte performed 12,310 darbepoetin injection (aranesp) for anemia services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Aponte receive payments from pharmaceutical companies?
Yes. Dr. Aponte received a total of $9,434 from 50 companies across 401 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Aponte's costs compare to other hematology & oncology specialists in San Antonio?
Dr. Aponte's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Aponte) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in San Antonio
Browse hematology & oncology specialists in San Antonio ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in TX
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in TX
Which TX hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology